Skip to main content
Springer logoLink to Springer
. 2018 Dec 11;42(3):484. doi: 10.1007/s00270-018-2143-5

Correction to: Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

Tim A Labeur 1,2, R Bart Takkenberg 3, Heinz-Josef Klümpen 1,2, Otto M van Delden 4,
PMCID: PMC6828183  PMID: 30539234

Correction to: Cardiovasc Intervent Radiol 10.1007/s00270-018-2118-6

Toward the end of the second paragraph in the Discussion section, there is a word missing in the sentence “This may indicate that hepatic decompensation following is caused by a severe underlying liver disease or an aggressive tumor biology compromising liver function.” It should read: “This may indicate that hepatic decompensation following TACE is caused by a severe underlying liver disease or an aggressive tumor biology compromising liver function.”

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Tim A. Labeur, Email: t.a.labeur@amc.nl

R. Bart Takkenberg, Email: r.b.takkenberg@amc.nl.

Heinz-Josef Klümpen, Email: h.klumpen@amc.nl.

Otto M. van Delden, Email: o.m.vandelden@amc.nl


Articles from Cardiovascular and Interventional Radiology are provided here courtesy of Springer

RESOURCES